Golden State Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17 Sell
2
-39
-95% -$260 ﹤0.01% 1608
2026
Q1
$224 Hold
41
﹤0.01% 1546
2025
Q4
$287 Sell
41
-61
-60% -$478 ﹤0.01% 1617
2025
Q3
$788 Sell
102
-595
-85% -$4.64K ﹤0.01% 1532
2025
Q2
$6.07K Sell
697
-950
-58% -$6.89K ﹤0.01% 1187
2025
Q1
$13.1K Hold
1,647
﹤0.01% 920
2024
Q4
$15K Buy
+1,647
New +$15.9K ﹤0.01% 842
2020
Q2
Sell
-10
Closed -$2K 858
2020
Q1
$2K Buy
+10
New +$1.16K ﹤0.01% 875

Other funds holding TDOC

Golden State Wealth Management's TDOC Position: Q2 2026 in Review

Golden State Wealth Management reduced its Teladoc Health (TDOC) stake by 95% in Q2 2026, selling an estimated $260 and leaving 2 shares worth $17. The position accounts for ﹤0.01% of the portfolio, ranked #1608.

Golden State Wealth Management first reported a position in TDOC in Q1 2020 and has held it in 8 quarters since. The position peaked at $15K in Q4 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Golden State Wealth Management held 2 shares of Teladoc Health worth $17 as of Q2 2026.
  • Golden State Wealth Management sold 39 Teladoc Health shares in Q2 2026, an estimated $260.
  • Teladoc Health made up ﹤0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #1608 holding.
  • Golden State Wealth Management first reported a position in Teladoc Health in Q1 2020 and has held it in 8 quarters since.
  • Golden State Wealth Management's Teladoc Health position peaked at $15K in Q4 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.